nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—Poisoning—Hydroxyurea—head and neck cancer	0.0448	0.0699	CcSEcCtD
Tranexamic Acid—Intoxication—Hydroxyurea—head and neck cancer	0.0448	0.0699	CcSEcCtD
Tranexamic Acid—PLG—mouth—head and neck cancer	0.0385	0.196	CbGeAlD
Tranexamic Acid—PLG—neck—head and neck cancer	0.0329	0.167	CbGeAlD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP8—head and neck cancer	0.0277	0.17	CbGpPWpGaD
Tranexamic Acid—PLG—connective tissue—head and neck cancer	0.0236	0.12	CbGeAlD
Tranexamic Acid—Thromboembolic event—Docetaxel—head and neck cancer	0.0233	0.0363	CcSEcCtD
Tranexamic Acid—PLG—epithelium—head and neck cancer	0.0224	0.114	CbGeAlD
Tranexamic Acid—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0205	0.032	CcSEcCtD
Tranexamic Acid—Digestion impaired—Hydroxyurea—head and neck cancer	0.0181	0.0282	CcSEcCtD
Tranexamic Acid—PLG—lymphoid tissue—head and neck cancer	0.0172	0.0878	CbGeAlD
Tranexamic Acid—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0148	0.0231	CcSEcCtD
Tranexamic Acid—PLG—head—head and neck cancer	0.0139	0.0707	CbGeAlD
Tranexamic Acid—SLC15A2—mouth—head and neck cancer	0.0123	0.0627	CbGeAlD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP8—head and neck cancer	0.0122	0.0751	CbGpPWpGaD
Tranexamic Acid—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0108	0.0169	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0107	0.0168	CcSEcCtD
Tranexamic Acid—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0103	0.0161	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0098	0.0153	CcSEcCtD
Tranexamic Acid—Embolism—Docetaxel—head and neck cancer	0.00977	0.0152	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00879	0.054	CbGpPWpGaD
Tranexamic Acid—SLC15A2—parotid gland—head and neck cancer	0.00856	0.0436	CbGeAlD
Tranexamic Acid—Dermatitis atopic—Docetaxel—head and neck cancer	0.00847	0.0132	CcSEcCtD
Tranexamic Acid—SLC15A2—saliva-secreting gland—head and neck cancer	0.0082	0.0418	CbGeAlD
Tranexamic Acid—Angina pectoris—Vinblastine—head and neck cancer	0.00809	0.0126	CcSEcCtD
Tranexamic Acid—Myocardial ischaemia—Docetaxel—head and neck cancer	0.0078	0.0122	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0073	0.0114	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Vinblastine—head and neck cancer	0.00726	0.0113	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—SOD2—head and neck cancer	0.00716	0.044	CbGpPWpGaD
Tranexamic Acid—Swelling—Fluorouracil—head and neck cancer	0.00715	0.0112	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—GPX1—head and neck cancer	0.00683	0.0419	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Vinblastine—head and neck cancer	0.00668	0.0104	CcSEcCtD
Tranexamic Acid—Haemorrhage—Vinblastine—head and neck cancer	0.00665	0.0104	CcSEcCtD
Tranexamic Acid—Respiratory failure—Docetaxel—head and neck cancer	0.00639	0.00996	CcSEcCtD
Tranexamic Acid—SLC15A2—trachea—head and neck cancer	0.00633	0.0322	CbGeAlD
Tranexamic Acid—Pulmonary embolism—Docetaxel—head and neck cancer	0.00627	0.00978	CcSEcCtD
Tranexamic Acid—Haemoglobin—Hydroxyurea—head and neck cancer	0.00609	0.00951	CcSEcCtD
Tranexamic Acid—Haemorrhage—Hydroxyurea—head and neck cancer	0.00606	0.00946	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT6—head and neck cancer	0.00603	0.037	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00568	0.0349	CbGpPWpGaD
Tranexamic Acid—Pulmonary oedema—Docetaxel—head and neck cancer	0.00558	0.00871	CcSEcCtD
Tranexamic Acid—Angiopathy—Hydroxyurea—head and neck cancer	0.0055	0.00858	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00542	0.0333	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Vinblastine—head and neck cancer	0.00537	0.00838	CcSEcCtD
Tranexamic Acid—Anaemia—Vinblastine—head and neck cancer	0.00535	0.00834	CcSEcCtD
Tranexamic Acid—Angina pectoris—Fluorouracil—head and neck cancer	0.00531	0.00828	CcSEcCtD
Tranexamic Acid—Malaise—Vinblastine—head and neck cancer	0.00522	0.00814	CcSEcCtD
Tranexamic Acid—Swelling—Docetaxel—head and neck cancer	0.00516	0.00805	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP8—head and neck cancer	0.00512	0.0315	CbGpPWpGaD
Tranexamic Acid—Convulsion—Vinblastine—head and neck cancer	0.00501	0.00782	CcSEcCtD
Tranexamic Acid—SLC15A2—thyroid gland—head and neck cancer	0.00501	0.0255	CbGeAlD
Tranexamic Acid—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0049	0.00764	CcSEcCtD
Tranexamic Acid—Anaemia—Hydroxyurea—head and neck cancer	0.00488	0.00761	CcSEcCtD
Tranexamic Acid—Discomfort—Vinblastine—head and neck cancer	0.00487	0.00759	CcSEcCtD
Tranexamic Acid—Visual disturbance—Docetaxel—head and neck cancer	0.0048	0.00749	CcSEcCtD
Tranexamic Acid—Atrial fibrillation—Docetaxel—head and neck cancer	0.0048	0.00749	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00479	0.00748	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Fluorouracil—head and neck cancer	0.00476	0.00743	CcSEcCtD
Tranexamic Acid—Malaise—Hydroxyurea—head and neck cancer	0.00476	0.00742	CcSEcCtD
Tranexamic Acid—Convulsion—Hydroxyurea—head and neck cancer	0.00457	0.00713	CcSEcCtD
Tranexamic Acid—Sinusitis—Fluorouracil—head and neck cancer	0.00456	0.00711	CcSEcCtD
Tranexamic Acid—Migraine—Docetaxel—head and neck cancer	0.00448	0.00699	CcSEcCtD
Tranexamic Acid—SLC15A2—head—head and neck cancer	0.00444	0.0226	CbGeAlD
Tranexamic Acid—Discomfort—Hydroxyurea—head and neck cancer	0.00444	0.00693	CcSEcCtD
Tranexamic Acid—Haemoglobin—Fluorouracil—head and neck cancer	0.00439	0.00684	CcSEcCtD
Tranexamic Acid—Haemorrhage—Fluorouracil—head and neck cancer	0.00436	0.00681	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00422	0.00659	CcSEcCtD
Tranexamic Acid—Cramp muscle—Docetaxel—head and neck cancer	0.0041	0.0064	CcSEcCtD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—head and neck cancer	0.00409	0.0251	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Fluorouracil—head and neck cancer	0.0039	0.00608	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Vinblastine—head and neck cancer	0.00389	0.00607	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00386	0.00602	CcSEcCtD
Tranexamic Acid—Dyspnoea—Hydroxyurea—head and neck cancer	0.00384	0.00599	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CDH1—head and neck cancer	0.00383	0.0236	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Docetaxel—head and neck cancer	0.00383	0.00598	CcSEcCtD
Tranexamic Acid—Dyspepsia—Hydroxyurea—head and neck cancer	0.00379	0.00591	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.00374	0.023	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Vinblastine—head and neck cancer	0.00373	0.00582	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL2—head and neck cancer	0.00372	0.0229	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00372	0.0058	CcSEcCtD
Tranexamic Acid—Fatigue—Hydroxyurea—head and neck cancer	0.00371	0.00579	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.00356	0.0219	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00355	0.00554	CcSEcCtD
Tranexamic Acid—Anaemia—Fluorouracil—head and neck cancer	0.00351	0.00548	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vinblastine—head and neck cancer	0.00348	0.00543	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00346	0.0054	CcSEcCtD
Tranexamic Acid—Renal failure—Docetaxel—head and neck cancer	0.00345	0.00538	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Docetaxel—head and neck cancer	0.00344	0.00536	CcSEcCtD
Tranexamic Acid—Asthenia—Vinblastine—head and neck cancer	0.00339	0.00529	CcSEcCtD
Tranexamic Acid—Convulsion—Fluorouracil—head and neck cancer	0.00329	0.00513	CcSEcCtD
Tranexamic Acid—Chest pain—Fluorouracil—head and neck cancer	0.00323	0.00505	CcSEcCtD
Tranexamic Acid—Myalgia—Fluorouracil—head and neck cancer	0.00323	0.00505	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vinblastine—head and neck cancer	0.00323	0.00504	CcSEcCtD
Tranexamic Acid—Discomfort—Fluorouracil—head and neck cancer	0.00319	0.00498	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00319	0.0196	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00317	0.00495	CcSEcCtD
Tranexamic Acid—Haemoglobin—Docetaxel—head and neck cancer	0.00317	0.00494	CcSEcCtD
Tranexamic Acid—Haemorrhage—Docetaxel—head and neck cancer	0.00315	0.00491	CcSEcCtD
Tranexamic Acid—Dizziness—Vinblastine—head and neck cancer	0.00312	0.00487	CcSEcCtD
Tranexamic Acid—SLC15A2—lymph node—head and neck cancer	0.00311	0.0158	CbGeAlD
Tranexamic Acid—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0031	0.00484	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.0031	0.019	CbGpPWpGaD
Tranexamic Acid—Asthenia—Hydroxyurea—head and neck cancer	0.00309	0.00482	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.00309	0.019	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Fluorouracil—head and neck cancer	0.00304	0.00474	CcSEcCtD
Tranexamic Acid—Visual impairment—Docetaxel—head and neck cancer	0.00303	0.00473	CcSEcCtD
Tranexamic Acid—Vomiting—Vinblastine—head and neck cancer	0.003	0.00468	CcSEcCtD
Tranexamic Acid—Headache—Vinblastine—head and neck cancer	0.00296	0.00462	CcSEcCtD
Tranexamic Acid—Diarrhoea—Hydroxyurea—head and neck cancer	0.00295	0.0046	CcSEcCtD
Tranexamic Acid—Eye disorder—Docetaxel—head and neck cancer	0.00294	0.00459	CcSEcCtD
Tranexamic Acid—Flushing—Docetaxel—head and neck cancer	0.00292	0.00456	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Docetaxel—head and neck cancer	0.00292	0.00456	CcSEcCtD
Tranexamic Acid—Hypotension—Fluorouracil—head and neck cancer	0.0029	0.00452	CcSEcCtD
Tranexamic Acid—Angiopathy—Docetaxel—head and neck cancer	0.00286	0.00446	CcSEcCtD
Tranexamic Acid—Dizziness—Hydroxyurea—head and neck cancer	0.00285	0.00444	CcSEcCtD
Tranexamic Acid—Immune system disorder—Docetaxel—head and neck cancer	0.00284	0.00444	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Docetaxel—head and neck cancer	0.00284	0.00443	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00282	0.00441	CcSEcCtD
Tranexamic Acid—Arrhythmia—Docetaxel—head and neck cancer	0.00281	0.00439	CcSEcCtD
Tranexamic Acid—Nausea—Vinblastine—head and neck cancer	0.0028	0.00438	CcSEcCtD
Tranexamic Acid—Dyspnoea—Fluorouracil—head and neck cancer	0.00276	0.00431	CcSEcCtD
Tranexamic Acid—Vomiting—Hydroxyurea—head and neck cancer	0.00274	0.00427	CcSEcCtD
Tranexamic Acid—Dyspepsia—Fluorouracil—head and neck cancer	0.00273	0.00426	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—head and neck cancer	0.00271	0.0167	CbGpPWpGaD
Tranexamic Acid—Headache—Hydroxyurea—head and neck cancer	0.0027	0.00421	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00268	0.00418	CcSEcCtD
Tranexamic Acid—Back pain—Docetaxel—head and neck cancer	0.00265	0.00414	CcSEcCtD
Tranexamic Acid—Muscle spasms—Docetaxel—head and neck cancer	0.00264	0.00411	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.00259	0.0159	CbGpPWpGaD
Tranexamic Acid—Nausea—Hydroxyurea—head and neck cancer	0.00256	0.00399	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Fluorouracil—head and neck cancer	0.00255	0.00399	CcSEcCtD
Tranexamic Acid—Anaemia—Docetaxel—head and neck cancer	0.00253	0.00395	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.00252	0.0155	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Docetaxel—head and neck cancer	0.00241	0.00376	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TP53—head and neck cancer	0.00239	0.0147	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—head and neck cancer	0.00239	0.0147	CbGpPWpGaD
Tranexamic Acid—Convulsion—Docetaxel—head and neck cancer	0.00238	0.00371	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—head and neck cancer	0.00233	0.00364	CcSEcCtD
Tranexamic Acid—Chest pain—Docetaxel—head and neck cancer	0.00233	0.00364	CcSEcCtD
Tranexamic Acid—Myalgia—Docetaxel—head and neck cancer	0.00233	0.00364	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—head and neck cancer	0.00231	0.0142	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Fluorouracil—head and neck cancer	0.00228	0.00356	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Docetaxel—head and neck cancer	0.00224	0.00349	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Docetaxel—head and neck cancer	0.00219	0.00342	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—GRP—head and neck cancer	0.00216	0.0132	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Fluorouracil—head and neck cancer	0.00212	0.00331	CcSEcCtD
Tranexamic Acid—Hypotension—Docetaxel—head and neck cancer	0.00209	0.00326	CcSEcCtD
Tranexamic Acid—Dizziness—Fluorouracil—head and neck cancer	0.00205	0.0032	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00204	0.00318	CcSEcCtD
Tranexamic Acid—Dyspnoea—Docetaxel—head and neck cancer	0.00199	0.00311	CcSEcCtD
Tranexamic Acid—Vomiting—Fluorouracil—head and neck cancer	0.00197	0.00308	CcSEcCtD
Tranexamic Acid—Dyspepsia—Docetaxel—head and neck cancer	0.00197	0.00307	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—head and neck cancer	0.00195	0.012	CbGpPWpGaD
Tranexamic Acid—Headache—Fluorouracil—head and neck cancer	0.00194	0.00303	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00193	0.00301	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—head and neck cancer	0.00193	0.00301	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Docetaxel—head and neck cancer	0.00184	0.00288	CcSEcCtD
Tranexamic Acid—Nausea—Fluorouracil—head and neck cancer	0.00184	0.00287	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00183	0.00285	CcSEcCtD
Tranexamic Acid—Abdominal pain—Docetaxel—head and neck cancer	0.00177	0.00276	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00177	0.0109	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Docetaxel—head and neck cancer	0.00165	0.00257	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—head and neck cancer	0.00161	0.00987	CbGpPWpGaD
Tranexamic Acid—Asthenia—Docetaxel—head and neck cancer	0.00161	0.0025	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—head and neck cancer	0.00156	0.00956	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Docetaxel—head and neck cancer	0.00153	0.00239	CcSEcCtD
Tranexamic Acid—Dizziness—Docetaxel—head and neck cancer	0.00148	0.00231	CcSEcCtD
Tranexamic Acid—Vomiting—Docetaxel—head and neck cancer	0.00142	0.00222	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.00142	0.0087	CbGpPWpGaD
Tranexamic Acid—Headache—Docetaxel—head and neck cancer	0.0014	0.00219	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—head and neck cancer	0.00139	0.00855	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—head and neck cancer	0.00133	0.00817	CbGpPWpGaD
Tranexamic Acid—Nausea—Docetaxel—head and neck cancer	0.00133	0.00207	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK1—head and neck cancer	0.00127	0.00778	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—head and neck cancer	0.00127	0.00777	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.0012	0.0074	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.00114	0.007	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KISS1—head and neck cancer	0.00113	0.00693	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—head and neck cancer	0.0011	0.00675	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.00108	0.00666	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—head and neck cancer	0.00102	0.00624	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.00094	0.00578	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRP—head and neck cancer	0.000929	0.00571	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT6—head and neck cancer	0.000902	0.00554	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—head and neck cancer	0.000897	0.00551	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—YAP1—head and neck cancer	0.000798	0.0049	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000768	0.00472	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL2—head and neck cancer	0.00073	0.00449	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—head and neck cancer	0.000621	0.00381	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK3—head and neck cancer	0.000587	0.00361	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK1—head and neck cancer	0.000559	0.00343	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—head and neck cancer	0.000485	0.00298	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—head and neck cancer	0.000469	0.00288	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HRAS—head and neck cancer	0.000448	0.00275	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—head and neck cancer	0.000396	0.00243	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH1—head and neck cancer	0.00036	0.00221	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—head and neck cancer	0.000248	0.00152	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—head and neck cancer	0.000241	0.00148	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—head and neck cancer	0.000233	0.00143	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—head and neck cancer	0.00021	0.00129	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—head and neck cancer	0.000208	0.00128	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—head and neck cancer	0.000199	0.00122	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK1—head and neck cancer	0.000189	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—head and neck cancer	0.000189	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—head and neck cancer	0.000164	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—head and neck cancer	0.000159	0.000977	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—head and neck cancer	0.000152	0.000934	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—head and neck cancer	0.000134	0.000825	CbGpPWpGaD
